Dr Reddy’s Laboratories
Dr Reddy's denied approval for Phase 3 trials of Sputnik Light Covid vaccine
After launching Sputnik V, Russia had introduced a new single-dose vaccine called Sputnik Light in May
Dr. Reddy's Labs to launch Covid drug 2-DG at Rs 990 per sachet
The company will make the drug available in hospitals across metros and Tier 1 cities in the initial weeks
'Dr Reddy's expects Sputnik V vaccine to get approval from Indian regulator soon'
Dr Reddy's has partnered with the Russia Direct Investment Fund to bring the Sputnik V vaccine to India and other countries, official said
Fujifilm partners with Dr Reddy's to sell Avigan for COVID-19 treatment
In June, Glenmark received regulatory approval for favipiravir, generic form of Avigan, as treatment for virus infections in India
Brokerages bullish on DRL
The net profit grew 30.62 per cent YoY to Rs 521.70 crore from Rs 399.40 crore the same quarter last year.
DRL profit drops by 29 per cent in Q3
DRL is one of the several companies that have been facing heat in its key US market.
Whatsapp groups get info before bourses
Select traders get information about some companies, including DRL, before official announcement.
Dr Reddy’s Laboratories drug fails tests, recalled
this is the third product recall by Dr Reddy’s Labs in 2017 due to quality issues.
Indian drug firms recalling two different drugs
Dr Reddy’s Laboratories and Aurobindo Pharma have separately started recalling two different drugs.